Literature DB >> 9774616

Comparison of four serological tests to determine the CagA or VacA status of Helicobacter pylori strains.

Y Yamaoka1, T Kodama, D Y Graham, K Kashima.   

Abstract

We compared four tests for antibodies to CagA or VacA, HelicoBlot 2. 0, RIDA Blot Helicobacter, CHIRON RIBA H. pylori SIA, and an enzyme-linked immunosorbent assay using recombinant CagA. Immunoblot assays were accurate for determining Helicobacter pylori status but poor for determining CagA or VacA status (accuracy, 66 to 80% for CagA status and 34 to 67% for VacA status). None can be recommended for determining CagA or VacA status.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774616      PMCID: PMC105352     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.

Authors:  J Parsonnet; G D Friedman; N Orentreich; H Vogelman
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; J Imanishi
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

3.  Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.

Authors:  D Y Graham; R M Genta; D P Graham; J E Crabtree
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

4.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.

Authors:  E J Kuipers; G I Pérez-Pérez; S G Meuwissen; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

5.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.

Authors:  T L Cover; C P Dooley; M J Blaser
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

6.  Serologic detection of infection with cagA+ Helicobacter pylori strains.

Authors:  T L Cover; Y Glupczynski; A P Lage; A Burette; M K Tummuru; G I Perez-Perez; M J Blaser
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

7.  Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.

Authors:  H M Mitchell; S L Hazell; Y Y Li; P J Hu
Journal:  Am J Gastroenterol       Date:  1996-09       Impact factor: 10.864

8.  Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls.

Authors:  C K Ching; B C Wong; E Kwok; L Ong; A Covacci; S K Lam
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

9.  Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham; A R Sepulveda
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

10.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

Authors:  M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  16 in total

1.  cagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease.

Authors:  Z Khodaii; S M H Ghaderian; R Akbarzadeh Najar; H Nejati; A S Tabatabaei Panah
Journal:  Ir J Med Sci       Date:  2010-08-20       Impact factor: 1.568

Review 2.  New immunological assays for the diagnosis of Helicobacter pylori infection.

Authors:  D Vaira; J Holton; M Menegatti; C Ricci; F Landi; A Ali'; L Gatta; C Acciardi; S Farinelli; M Crosatti; S Berardi; M Miglioli
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 3.  Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.

Authors:  Seiji Shiota; Yoshio Yamaoka
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

4.  Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia.

Authors:  T M Peters; R J Owen; E Slater; R Varea; E L Teare; S Saverymuttu
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

5.  Immunoblot analysis of humoral immune response to Helicobacter pylori in children with and without duodenal ulcer.

Authors:  G A Rocha; A M Oliveira; D M Queiroz; A S Carvalho; A M Nogueira
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Detection of H. pylori infection by ELISA and Western blot techniques and evaluation of anti CagA seropositivity in adult Turkish dyspeptic patients.

Authors:  Ozlem Yilmaz; Nazime Sen; Ahmet Ali Küpelioğlu; Ilkay Simşek
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

7.  New serological assay for detection of putative Helicobacter pylori virulence factors.

Authors:  Chang-Young Park; Yong-Kyun Cho; Tadashi Kodama; Hala M T El-Zimaity; Michael S Osato; David Y Graham; Yoshio Yamaoka
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

8.  Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.

Authors:  Lea Veijola; Aino Oksanen; Pentti Sipponen; Hilpi Rautelin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

9.  Accuracy of a commercial enzyme-linked immunosorbent assay for CagA in patients from Brazil with and without gastric carcinoma.

Authors:  Andreia Maria Camargos Rocha; Gifone Aguiar Rocha; Adriana Santos; Celso Affonso de Oliveira; Dulciene Maria Magalhães Queiroz
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.

Authors:  N Broutet; M Plebani; C Sakarovitch; P Sipponen; F Mégraud
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.